Societal CDMO - SCTL Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $1.80
  • Forecasted Upside: 63.64%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.10
▲ +0.01 (0.92%)
Get New Societal CDMO Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SCTL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SCTL

Analyst Price Target is $1.80
▲ +63.64% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Societal CDMO in the last 3 months. The average price target is $1.80, with a high forecast of $2.50 and a low forecast of $1.10. The average price target represents a 63.64% upside from the last price of $1.10.

This chart shows the closing price for SCTL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 investment analysts is to moderate buy stock in Societal CDMO. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/31/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/29/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/26/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/25/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/24/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/29/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Sector Perform$1.25 ➝ $1.10Low
11/9/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$2.00 ➝ $1.25Low
11/9/2023William BlairReiterated RatingOutperformLow
8/15/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$2.00Low
8/15/2023StephensReiterated RatingOverweight ➝ Overweight$2.50Low
3/23/2023Royal Bank of CanadaInitiated CoverageOutperform$2.00Low
9/9/2022William BlairReiterated RatingOutperformLow
(Data available from 6/24/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/27/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/26/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2024
  • 2 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/26/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Societal CDMO logo
Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. The company provides end-to-end services, such as formulation development focusing on complex formulations, reformulation, physical characterization, and excipient compatibility; analytical methods development which offers a range of analytical testing capabilities, including product testing, ICH stability, method development and validation, chromatography and spectroscopy equipment, stability chambers, and microbial testing; and pharmaceutical manufacturing that provides milling, blending, compression, spray and rotary granulation, particle and bead coating, encapsulation, liquids, lyophilization, and sterile fill and finish services. It also offers regulatory support, including handling communications with the food and drug administration (FDA) and seek consultation and guidance for client FDA meetings and responses; and pharmaceutical packaging and logistics, as well as smaller-scale primary and secondary packaging, labeling and kitting options suited for clinical trial materials and development packaging needs across dosage forms. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
Read More

Today's Range

Now: $1.10
Low: $1.09
High: $1.10

50 Day Range

MA: $1.09
Low: $1.06
High: $1.10

52 Week Range

Now: $1.10
Low: $0.26
High: $1.28

Volume

514,600 shs

Average Volume

957,342 shs

Market Capitalization

$116.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.61

Frequently Asked Questions

What sell-side analysts currently cover shares of Societal CDMO?

The following equities research analysts have issued research reports on Societal CDMO in the last twelve months: Royal Bank of Canada, Stephens, and William Blair.
View the latest analyst ratings for SCTL.

What is the current price target for Societal CDMO?

2 Wall Street analysts have set twelve-month price targets for Societal CDMO in the last year. Their average twelve-month price target is $1.80, suggesting a possible upside of 63.6%. Stephens has the highest price target set, predicting SCTL will reach $2.50 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $1.10 for Societal CDMO in the next year.
View the latest price targets for SCTL.

What is the current consensus analyst rating for Societal CDMO?

Societal CDMO currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SCTL.

What other companies compete with Societal CDMO?

How do I contact Societal CDMO's investor relations team?

Societal CDMO's physical mailing address is 1 E. UWCHLAN AVE SUITE 112, EXTON PA, 19341. The company's listed phone number is (770) 534-8239 and its investor relations email address is [email protected]. The official website for Societal CDMO is www.recrocdmo.com. Learn More about contacing Societal CDMO investor relations.